JHS SVENDGAARD LABORATORIES LTD. - 532771 - Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- KIRTI MAHESHWARIDesignation :- Company Secretary and Compliance Officer JHS SVENDGAARD LABORATORIES LTD. - 532771 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith copies of newspaper advertisement(s) given by the company in relation to 16th Annual General Meeting (AGM) of the Company Published in Business Standard English, (All Edition) and Business Standard Hindi, (Chandigarh Edition) on 18th July, 2020 confirming the completion of dispatch of Notice of AGM and Annual Report (2019-20) to the members of the Company and providing other relevant information in that behalf. The said publications are also being made available on the website of the company i.e. https:/www.svendgaard.com. JHS SVENDGAARD LABORATORIES LTD. - 532771 - Reg. 34 (1) Annual Report
ANNUAL REPORT FOR THE FINANCIAL YEAR 2019-2020. JHS SVENDGAARD LABORATORIES LTD. - 532771 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith copies of newspaper advertisement(s) given by the company in relation to Annual General Meeting of the Company published in Business Standard English, All Edition and Business Standard Hindi Chandigarh Edition. The said publications are also being made available on the website of the company i.e. https://www.svendgaard.com. JHS SVENDGAARD LABORATORIES LTD. - 532771 - Announcement under Regulation 30 (LODR)-Meeting Updates
Pursuant to the applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), including Regulation 30, this is to inform you that the Board of Directors of JHS Svendgaard Laboratories Limited ('the Company'), at their meeting held today, i.e. on July 11, 2020, has inter alia considered and approved; 1.the re-appointment of Mr. Mukul Pathak (DIN: 00051534) as an Independent Director of the Company from 02nd July, 2020 for a period of 5 years subject to approval of shareholders. 2.the re-appointment of M/s S.N. Dhawan & Co. LLP (FRN: 000050N/N500045) as Statutory Auditors for a period of 5 years. 3.the alteration of Object Clause of Memorandum of Association (subject to approval of members of the Company at the ensuing Annual General meeting of the Company). JHS SVENDGAARD LABORATORIES LTD. - 532771 - Announcement under Regulation 30 (LODR)-Change in Directorate
Pursuant to the applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), including Regulation 30, this is to inform you that the Board of Directors of JHS Svendgaard Laboratories Limited ('the Company'), at their meeting held today, i.e. on July 11, 2020, has inter alia considered and approved; 1. the re-appointment of Mr. Mukul Pathak (DIN: 00051534) as an Independent Director of the Company from 02nd July, 2020 for a period of 5 years subject to approval of shareholders. 2.the re-appointment of M/s S.N. Dhawan & Co. LLP (FRN: 000050N/N500045) as Statutory Auditors for a period of 5 years. . 3.the alteration of Object Clause of Memorandum of Association (subject to approval of members of the Company at the ensuing Annual General meeting of the Company) by adding a new clause for the purpose enabling the Company to explore the possibilities to diversify the existing business of the Company into automobile parts. JHS SVENDGAARD LABORATORIES LTD. - 532771 - Closure of Trading Window
We would like to inform you that in pursuant to Schedule B to the SEBI (Prohibition of Insider Trading) Regulations 2015, as amended, read with 'Code of Conduct for Prevention of Insider Trading' and 'Code of Conduct for Practices and Procedures Fair Disclosure of Unpublished Price Sensitive Information (UPSI)', the 'Trading Window' of the company shall remain closed for trading in company's securities by Designated Persons, Connected Persons as defined in the aforesaid 'Code of Conducts' and immediate relative thereof from 01st July, 2020 till the end of 48 hours after the declaration of financial results for Quarter ended 30th June, 2020. The date of Board Meeting of the Company for consideration and declaration of the Financial Results for the Quarter ended 30th June, 2020 will be intimated in due course. JHS SVENDGAARD LABORATORIES LTD. - 532771 - Undertaking Pursuant To SEBI Circular SEBI/HO/DDHS/CIR/2018/144 Dated 26Th November, 2018 On The Subject 'Fund Raising By Issuance Of Debt Securities By Large Entities'
With reference to the captioned SEBI CIRCULAR SEBI/HO/DDHS/CIR/P/2018/144 Dated 26th November 2018 - on the subject 'Fund Raising by Issuance of Debt Securities by Large Entities' and disclosures and compliance thereof by such Large Corporates (LC). In this connection we hereby submit that our company JHS Svendgaard Laboratories Limited does not fall under the Large Corporates category as per the framework provided in the aforesaid circular. JHS SVENDGAARD LABORATORIES LTD. - 532771 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Please find enclosed herewith the Secretarial Compliance Report as per Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended on 31st March, 2020. JHS SVENDGAARD LABORATORIES LTD. - 532771 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
JHS Svendgaard Laboratories Limited announces Consolidated FY 19-20 results Consolidated revenue grows to Rs.152.95 crore. JHS Svendgaard Laboratories Ltd. (JHS) one of India's leading Oral-care manufacturing company reported its financial results for the fourth quarter and year ending 31st March, 2020. FY 19-20 Highlights (Consolidated): ? Total Income at Rs.152.95 crore ? EBITDA at Rs.15.51 crore ? EBITDA Margin at 10.14% ? Total Income were at Rs.130.78 crore ? EBITDA was at Rs.6.08 crore ? EBITDA Margin stood at 4.65% ? Net loss before exceptional Items and Tax was at Rs.2.04 crore FY 19-20 Highlights (Standalone): ? Total Income at Rs.144.71 crore ? EBITDA at Rs.21.22 crore ? EBITDA Margin at 14.66 % ? Net Profit before exceptional Items and Tax at Rs.12.43 crore